Question · asked by 1 review
FLUPENTHIXOL DECANOATE vs other depot antipsychotic drugs: Economic outcomes ‐ long term ‐ not reported
- Population
- patients with schizophrenia or related psychoses
- Intervention
- FLUPENTHIXOL DECANOATE
- Comparison
- other depot antipsychotic drugs
- Outcome
- Economic outcomes ‐ long term ‐ not reported
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
FLUPENTHIXOL DECANOATE vs OTHER DEPOT ANTIPSYCHOTICS Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or other similar psychotic disorders The review found no eligible studies for this question. Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- FLUPENTHIXOL DECANOATE vs GENERAL ORAL ANTIPSYCHOTICS · patients with schizophrenia or related psychoses · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.